We are recruiting 15 Early Stage Researchers to work on the INSPiRE-MED European project.
We seek highly motivated and qualified individuals to fill the 15 Early Stage Researcher three-years positions available in the project. The successful candidates will contribute to the development of advanced biomedical research tools in the field of Magnetic Resonance Spectroscopy and Imaging, and its application to the clinical day-to-day practice.
Before applying, note that Early Stage Researchers are subject to the Eligibility and Mobility Rules:
- Early-Stage Researchers shall, at the time of recruitment by the host organisation, be in the first four years (full-time equivalent research experience) of their research careers and have not been awarded a doctoral degree.
- At the time of recruitment by the host organisation, researchers must not have resided or carried out their main activity (work, studies, etc.) in the country of their host organisation for more than 12 months in the 3 years immediately prior to the reference date.
The available positions are:
ESR 1: Optimized sets of MRS scans for fingerprinting and dedicated parameter estimation by fitting or deep learning. At Universität Bern, Switzerland.
ESR 2: Maximize metabolic information in a multi-parametric study at ultra-high field, from pre-clinical to clinical validations. At École Polythechnique Fédérale de Lausanne, Switzerland.
ESR 3: Next generation of multinuclear MRS(I). At MR Code B.V., Utrecht, The Netherlands.
ESR 4: Implementation of high-resolution MRSI methods in a pre-clinical scanner, and optimization for brain longitudinal studies of therapy response in mice glioma models. At Universitat Autònoma de Barcelona, Spain.
ESR 5: Efficient quantum-mechanics based simulation of metabolite excitation for fingerprinting and iterative parameter estimation. At Ustav pristrojove techniky AVCR, v. v. i. (Institute of Scientific Instruments of the Czech Academy of Sciences), Brno, Czech Republic.
ESR 6: Quantification and cross-validation of metabolic biomarkers in preclinical disease models. At Katholieke Universiteit Leuven, Belgium.
ESR 7: Development of automatic pipelines for MRS(I)/PET data processing and machine learning methods for prognostic and classification in Multiple Sclerosis patients. At Université Claude Bernard-Lyon1, Lyon, France) –
ESR 8: Pathophysiology of Tourette syndrome: multimodal characterization of metabolic alterations. At Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften Ev (Max Planck Institute for Human Cognitive and Brain Sciences), Leipzig, Germany.
ESR9: Glutamate neurotransmission in depression: combining receptor and metabolic information from simultaneous MR/PET. At The University of Manchester, United Kingdom.
ESR10: Integrated acquisition & post-processing of MR spectroscopic imaging (MRSI) data of the prostate. At Radboud University Medical Center, Nijmegen, The Netherlands.
ESR11: Automated nosologic imaging by fusing multiparametric MR information in longitudinal patient follow-up. At Katholieke Universiteit Leuven, Belgium.
ESR12: A decision-support system based on MRSI data at 3T, for glioblastoma therapy response follow- up. At Consorcio Centro de Investigacion Biomédica en Red M.P. (CIBER), Barcelona, Spain.
ESR13: Boosting the academic jMRUI with novel algorithms and data format standardization. At Ustav pristrojove techniky AVCR, v. v. i. (Institute of Scientific Instruments of the Czech Academy of Sciences), Brno, Czech Republic.
ESR14: Validation and CE documentation of a Magnetic Resonance Spectroscopy clinical pipeline as a medical device. At ICOMETRIX N.V., Leuven, Belgium.
ESR15: Development of robust, user-friendly analysis and reporting tools for automatic MRS(I) processing for use in a clinical setting. At Universitätsspital Bern, Switzerland.
To apply to one or more of the available positions, follow the instructions at the bottom of their description document at the INSPiRE-MED website or click the “Where to apply” button in the description pages at the EURAXESS jobs portal.
© 2019, MRUI Consortium. All rights reserved by MRUI Consortium except for texts and images already copyrighted by third parties (e.g. journal publishers) and used here according to their licensing terms and/or under the fair use provision.